UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P106 De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer: patterns of recurrence from a real-world single-centre cohort of patients

Breast (Edinburgh), 2023-04, Vol.68, p.S55-S55

2023

Volltextzugriff (PDF)

Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer

Clinical & translational oncology, 2019-07, Vol.21 (7), p.933-938

2019

Volltextzugriff (PDF)

Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience

Cancer treatment and research communications, 2019-01, Vol.19, p.100124-100124, Article 100124

2019

Volltextzugriff (PDF)

Résultats français d’une enquête internationale sur les « patient-reported outcomes » électroniques réalisée par le Young Radiation Oncology Group de l’European Organization for the Research and Treatment of Cancer

Cancer radiothérapie, 2019-10, Vol.23 (6-7), p.838-839

2019

Volltextzugriff (PDF)

OC-0336: Evaluation of bowel for online adaptive stereotactic radiotherapy of abdominal oligometastases

Radiotherapy and oncology, 2020-11, Vol.152, p.S176-S177

2020

Volltextzugriff (PDF)

PO-1658: Online-adaptive SRT with automated Organ At Risk contouring for abdominal oligometastases: Results

Radiotherapy and oncology, 2020-11, Vol.152, p.S909-S910

2020

Volltextzugriff (PDF)

PO-1263 The role of radiation therapy in patients with repeat or induced oligometastatic breast cancer

Radiotherapy and oncology, 2023-05, Vol.182, p.S1009-S1010

2023

Volltextzugriff (PDF)

PO-1770 Robotic preoperative breast radiotherapy: tracking uncertainties and dosimetric implications

Radiotherapy and oncology, 2021-08, Vol.161, p.S1497-S1499

2021

Volltextzugriff (PDF)

The right ventricle is not spared by the cardiotoxic effects of chemotherapy for breast cancer. Results of SAFE trial

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Diastolic function is more sensitive than GLS in identifing cardiotoxicity. The SAFE trial results

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Three Months PSA Response after PSMA-Guided Approach for Biochemical Relapse after Prostatectomy (PSICHE Trial)

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e411-e411

2023

Volltextzugriff (PDF)

536P Safety and efficacy of silibinin in patients with brain metastases after stereotactic radiosurgery (SRS): The SUSTAIN trial

Annals of oncology, 2023-10, Vol.34, p.S404-S405

2023

Volltextzugriff (PDF)

SOC-III-03 Pulmonary toxicity of graphene based materials is governed by size-dependant biodegradation and clearance in alveolar phagocytes

Toxicology letters, 2022-09, Vol.368, p.S43-S44

2022

Volltextzugriff (PDF)

379P Safety and efficacy of trastuzumab deruxtecan and concomitant radiation therapy in patients with metastatic breast cancer: A multicentre international retrospective cohort study

Annals of oncology, 2024-09, Vol.35, p.S377-S378

2024

Volltextzugriff (PDF)

Prepectoral breast reconstruction with tissue expander covered by acellular dermal matrix: results and outcomes after the first 94 procedures

European journal of cancer (1990), 2024-03, Vol.200, p.113743, Article 113743

2024

Volltextzugriff (PDF)

Ductal carcinoma in situ of the breast, lessons learned after more than 10 years follow-up of a cohort of patients from a large western cancer centre

European journal of cancer (1990), 2024-03, Vol.200, p.113744, Article 113744

2024

Volltextzugriff (PDF)

PO-1109 Safety and efficacy of silibinin in patients with brain metastases after SRS: SUSTAIN trial

Radiotherapy and oncology, 2023-05, Vol.182, p.S886-S887

2023

Volltextzugriff (PDF)

Single center analysis of safety profile and survival outcomes of intracranial radiation therapy in combination with trastuzumab-emtansine (T-DM1)

European journal of cancer (1990), 2024-03, Vol.200, p.113706, Article 113706

2024

Volltextzugriff (PDF)

Safety of trastuzumab deruxtecan and radiation therapy combination in HER2-positive metastatic breast cancer patients

European journal of cancer (1990), 2024-03, Vol.200, p.113730, Article 113730

2024

Volltextzugriff (PDF)

Cardioprotection beyond the guidelines: the SAFE trial results

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Comparison Between Accelerated Partial Breast Irradiation and Whole Breast Irradiation: APBI IMRT Florence Retrospective Analysis of Subjective, Objective and Patient-reported Cosmetic Outcomes

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.S153-S153

2020

Volltextzugriff (PDF)

Clinical Outcomes and Dosimetric Predictive Factors in Patients Undergoing Reirradiation for Recurrent Meningiomas

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e106-e107

2023

Volltextzugriff (PDF)

PO-1137 Safety And Efficacy Of Silibinin In Patients With Brain Metastases after Radiosurgery: Sustain Trial

Radiotherapy and oncology, 2022-05, Vol.170, p.S965-S966

2022

Volltextzugriff (PDF)

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

The Lancet (British edition), 1999-04, Vol.353 (9162), p.1386-1389

1999

Volltextzugriff (PDF)

PO-1354 Pattern of failure after stereotactic body radiotherapy to liver metastases: impact of local control

Radiotherapy and oncology, 2023-05, Vol.182, p.S1085-S1086

2023

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(336)
Mit Volltextzugriff
(297)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(175)
Humans
(153)
Life Sciences & Biomedicine
(150)
Male
(106)
Female
(105)
Middle Aged
(89)
Adult
(88)
Hematology
(82)
Biological And Medical Sciences
(78)
Medical Sciences
(73)
Aged
(69)
Adolescent
(37)
Oncology
(37)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(28)
Hematologic And Hematopoietic Diseases
(28)
Aged, 80 And Over
(26)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(25)
Pharmacology. Drug Treatments
(22)
Prognosis
(22)
Treatment Outcome
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

P106 De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer: patterns of recurrence from a real-world single-centre cohort of patients

Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer

Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience

Résultats français d’une enquête internationale sur les « patient-reported outcomes » électroniques réalisée par le Young Radiation Oncology Group de l’European Organization for the Research and Treatment of Cancer

OC-0336: Evaluation of bowel for online adaptive stereotactic radiotherapy of abdominal oligometastases

PO-1658: Online-adaptive SRT with automated Organ At Risk contouring for abdominal oligometastases: Results

PO-1263 The role of radiation therapy in patients with repeat or induced oligometastatic breast cancer

PO-1770 Robotic preoperative breast radiotherapy: tracking uncertainties and dosimetric implications

The right ventricle is not spared by the cardiotoxic effects of chemotherapy for breast cancer. Results of SAFE trial

Diastolic function is more sensitive than GLS in identifing cardiotoxicity. The SAFE trial results

Three Months PSA Response after PSMA-Guided Approach for Biochemical Relapse after Prostatectomy (PSICHE Trial)

536P Safety and efficacy of silibinin in patients with brain metastases after stereotactic radiosurgery (SRS): The SUSTAIN trial

SOC-III-03 Pulmonary toxicity of graphene based materials is governed by size-dependant biodegradation and clearance in alveolar phagocytes

379P Safety and efficacy of trastuzumab deruxtecan and concomitant radiation therapy in patients with metastatic breast cancer: A multicentre international retrospective cohort study

Prepectoral breast reconstruction with tissue expander covered by acellular dermal matrix: results and outcomes after the first 94 procedures

Ductal carcinoma in situ of the breast, lessons learned after more than 10 years follow-up of a cohort of patients from a large western cancer centre

PO-1109 Safety and efficacy of silibinin in patients with brain metastases after SRS: SUSTAIN trial

Single center analysis of safety profile and survival outcomes of intracranial radiation therapy in combination with trastuzumab-emtansine (T-DM1)

Safety of trastuzumab deruxtecan and radiation therapy combination in HER2-positive metastatic breast cancer patients

Cardioprotection beyond the guidelines: the SAFE trial results

Comparison Between Accelerated Partial Breast Irradiation and Whole Breast Irradiation: APBI IMRT Florence Retrospective Analysis of Subjective, Objective and Patient-reported Cosmetic Outcomes

Clinical Outcomes and Dosimetric Predictive Factors in Patients Undergoing Reirradiation for Recurrent Meningiomas

PO-1137 Safety And Efficacy Of Silibinin In Patients With Brain Metastases after Radiosurgery: Sustain Trial

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

PO-1354 Pattern of failure after stereotactic body radiotherapy to liver metastases: impact of local control

Suchergebnisse filtern